Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2677 |
|
Actual shortage: | 255 (10%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2413 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (9%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACT RANITIDINE | 150MG | TABLET | Resolved | 2019-09-26 | 2020-05-14 | 94849 |
ACT RANITIDINE | 150MG | TABLET | Resolved | 2019-09-26 | 2020-05-14 | 94852 |
ACT RANITIDINE | 300MG | TABLET | Resolved | 2019-09-26 | 2020-05-14 | 94855 |
TEVA-PRAVASTATIN | 40MG | TABLET | Resolved | 2019-09-26 | 2020-08-21 | 94858 |
TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2019-09-26 | 2019-10-10 | 94861 |
TEVA-LEVOCARBIDOPA | 25MG 100MG | TABLET | Resolved | 2019-09-26 | 2019-10-10 | 94864 |
TEVA-PRAVASTATIN | 20MG | TABLET | Resolved | 2019-09-26 | 2020-01-17 | 94867 |
PORTIA 21 | 0.03MG 0.15MG | TABLET | Resolved | 2019-09-26 | 2019-10-10 | 94870 |
PORTIA 28 | 0.03MG 0.15MG | TABLET | Resolved | 2019-09-26 | 2019-10-10 | 94874 |
TEVA-FAMOTIDINE | 20MG | TABLET | Resolved | 2019-09-26 | 2020-03-10 | 94877 |
TEVA-FAMOTIDINE | 40MG | TABLET | Resolved | 2019-09-26 | 2020-03-10 | 94880 |
TEVA-BUPRENORPHINE/NALOXONE | 8MG 2MG | TABLET | Resolved | 2019-09-26 | 2020-01-24 | 94896 |
SEASONIQUE | 0.01MG 0.03MG 0.15MG | TABLET | Resolved | 2019-09-26 | 2021-03-25 | 94905 |
SEASONALE | 0.03MG 0.15MG | TABLET | Resolved | 2019-09-27 | 2019-09-27 | 94940 |
TEVA-LACOSAMIDE | 150MG | TABLET | Resolved | 2019-10-03 | 2019-10-10 | 95387 |
TEVA-SIMVASTATIN | 80MG | TABLET | Resolved | 2019-10-03 | 2020-09-03 | 95390 |
TEVA-BUPRENORPHINE/NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2019-10-03 | 2020-01-24 | 95396 |
TEVA-CEPHALEXIN | 250MG | TABLET | Resolved | 2019-10-10 | 2019-11-28 | 96076 |
ACT QUETIAPINE | 25MG | TABLET | Resolved | 2019-10-10 | 2020-03-05 | 96079 |
TEVA-ROPINIROLE | 0.25MG | TABLET | Resolved | 2019-10-17 | 2020-04-02 | 96714 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64541 |
TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64601 |
TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64606 |
TEVA-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64609 |
TEVA-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64612 |
TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64846 |
TEVA-QUETIAPINE | 25MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64849 |
TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64855 |
TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64858 |
TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64861 |
TEVA-ENALAPRIL | 16MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64866 |
TEVA-ENALAPRIL | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64869 |
TEVA-LISINOPRIL (TYPE P) | 5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64909 |
NOVO-PROFEN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64920 |
TEVA-CLONAZEPAM | 0.5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64923 |
TEVA-CLONAZEPAM | 0.5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64926 |
TEVA-CLONAZEPAM | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64929 |
TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64970 |
TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64975 |
TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64983 |